Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

(2010) T.-C. Chou   CANCER RESEARCH

Resveratrol: Its Biologic Targets and Functional Activity

(2009) Shazib Pervaiz et al.   ANTIOXIDANTS & REDOX SIGNALING

Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance

(2009) A. V. Kurtova et al.   BLOOD

Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia

(2009) K Giannopoulos et al.   LEUKEMIA

Resveratrol induces senescence-like growth inhibition of U-2 OS cells associated with the instability of telomeric DNA and upregulation of BRCA1

(2009) Marek Rusin et al.   MECHANISMS OF AGEING AND DEVELOPMENT

Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells

(2008) Amel Baya Bouzar et al.   BRITISH JOURNAL OF HAEMATOLOGY

Thalidomide induces phosphorylation of histone H2AX and increases rate of apoptosis caused by fludarabine in malignant lymphocytes of chronic lymphocytic leukemia in short-term cell cultures

(2008) Monika Podhorecka et al.   LEUKEMIA RESEARCH